Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis

…, M Losi, R Markova, GB Migliori… - European …, 2011 - Eur Respiratory Soc
We conducted a systematic review and meta-analysis to compare the accuracy of the
QuantiFERON-TB® Gold In-Tube (QFT-G-IT) and the T-SPOT®.TB assays with the tuberculin skin …

Universal use of face masks for success against COVID-19: evidence and implications for prevention policies

…, N Principi, CC Leung, GB Migliori - European Respiratory …, 2020 - Eur Respiratory Soc
GB Migliori and CC Leung wrote sections of the manuscript, edited the text for major intellectual
components and designed the … Conflict of interest: GB Migliori has nothing to disclose. …

Towards tuberculosis elimination: an action framework for low-incidence countries

K Lönnroth, GB Migliori, I Abubakar… - European …, 2015 - Eur Respiratory Soc
This paper describes an action framework for countries with low tuberculosis (TB) incidence
(<100 TB cases per million population) that are striving for TB elimination. The framework …

[HTML][HTML] Gauging the impact of the COVID-19 pandemic on tuberculosis services: a global study

GB Migliori, PM Thong, JW Alffenaar… - European …, 2021 - Eur Respiratory Soc
The effects of the coronavirus disease 2019 (COVID-19) pandemic on tuberculosis (TB)
disease and TB services emerged in the beginning of 2020 [1, 2]. Epidemiological and clinical …

Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis

…, G Sotgiu, A Zumla, GB Migliori - The Lancet infectious …, 2010 - thelancet.com
Multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis are generally
thought to have high mortality rates. However, many cases can be treated with the right …

Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosis

…, G Theron, Z Udwadia, GB Migliori… - The lancet Respiratory …, 2014 - thelancet.com
Extensively drug-resistant tuberculosis is a burgeoning global health crisis mainly affecting
economically active young adults, and has high mortality irrespective of HIV status. In some …

LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement

U Mack, GB Migliori, M Sester… - European …, 2009 - Eur Respiratory Soc
Tuberculosis control relies on the identification and preventive treatment of individuals who
are latently infected with Mycobacterium tuberculosis. However, direct identification of latent …

WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update

…, C Lienhardt, C Lu, A Mariandyshev, GB Migliori… - 2011 - Eur Respiratory Soc
The production of guidelines for the management of drug-resistant tuberculosis (TB) fits the
mandate of the World Health Organization (WHO) to support countries in the reinforcement of …

Official American thoracic society/centers for disease control and prevention/infectious diseases society of America clinical practice guidelines: treatment of drug …

…, G Sotgiu, JR Starke, GB Migliori… - Clinical infectious …, 2016 - academic.oup.com
The American Thoracic Society, Centers for Disease Control and Prevention, and Infectious
Diseases Society of America jointly sponsored the development of this guideline for the …

Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries

…, PG Suarez, KM Kam, AG Khomenko, GB Migliori… - Jama, 2000 - jamanetwork.com
ContextNo large-scale study has investigated the impact of multidrug-resistant tuberculosis (TB)
on the outcome of standard short-course chemotherapy under routine countrywide TB …